Nipro Corp. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
84,957
112,871
126,667
123,188
141,940
129,438
Total Accounts Receivable
101,169
111,694
112,252
119,660
139,074
147,722
Inventories
90,485
102,474
102,701
115,328
129,217
137,924
Other Current Assets
19,508
23,307
26,497
28,598
25,813
27,867
Total Current Assets
296,119
350,346
368,117
386,775
436,047
442,953
Net Property, Plant & Equipment
191,593
220,195
223,756
244,222
270,273
284,483
Total Investments and Advances
69,221
60,454
52,525
64,674
62,943
61,373
Intangible Assets
42,216
44,369
44,913
43,836
45,994
39,398
Other Assets
12,052
12,043
15,624
11,871
7,793
6,277
Total Assets
621,221
698,577
710,681
754,748
828,658
849,273
ST Debt & Current Portion LT Debt
157,543
175,027
139,154
144,200
130,079
Accounts Payable
45,661
51,750
56,185
57,587
62,105
Income Tax Payable
10,734
3,934
4,266
4,304
4,993
Other Current Liabilities
36,776
47,690
52,542
45,701
54,009
Total Current Liabilities
250,714
278,401
252,147
251,792
251,186
Long-Term Debt
225,901
230,961
273,113
316,088
384,993
Provision for Risks & Charges
4,775
4,376
5,588
5,806
5,379
Deferred Taxes
6,477
5,737
1,962
307
2,923
Other Liabilities
328
596
542
974
929
Total Liabilities
485,261
519,767
535,174
578,335
645,169
Common Equity (Total)
125,427
167,660
165,998
166,083
172,622
Total Shareholders' Equity
125,427
167,660
165,998
166,083
172,622
Total Equity
135,960
178,810
175,507
176,408
183,485
Liabilities & Shareholders' Equity
621,221
698,577
710,681
754,743
828,654
Accumulated Minority Interest
10,533
11,150
9,509
10,325
10,863

About Nipro

View Profile
Address
3-9-3 Honjo-Nishi
Osaka Osaka 531
Japan
Employees -
Website http://www.nipro.co.jp
Updated 07/08/2019
Nipro Corp. engages in the manufacture and sale of medical equipment, pharmaceutical products, and glass products. Its operations are carried out through the following segments: Medical related, Pharmaceutical related, Pharma Packaging, and Others. The Medical related segment provides injection and infusion-related products, artificial organ-related products, functional products, and dialysis and diabetes-related products.